Overview

NA-Semax Amidate is the most advanced form of Semax (Met-Glu-His-Phe-Pro-Gly-Pro), incorporating dual chemical modifications — N-terminal acetylation and C-terminal amidation — to create the most enzymatically stable variant in the Semax family. The parent compound Semax, developed at the Institute of Molecular Genetics of the Russian Academy of Sciences, is a synthetic heptapeptide based on the ACTH(4-10) fragment with a C-terminal Pro-Gly-Pro extension that confers resistance to proline-specific peptidases. While N-Acetyl Semax protects the N-terminal methionine from aminopeptidase degradation, the additional amidation in NA-Semax Amidate blocks carboxypeptidase attack at the C-terminus, creating comprehensive protection against both major exopeptidase pathways and maximizing the compound's biological half-life and CNS bioavailability.

The neurobiological effects of NA-Semax Amidate are mediated through multiple convergent mechanisms. The compound is among the most potent known inducers of brain-derived neurotrophic factor (BDNF) and its high-affinity receptor TrkB in the hippocampus, prefrontal cortex, and basal forebrain — the neural substrates of learning, memory, and executive function. BDNF activation drives synaptic plasticity, long-term potentiation, dendritic branching, and adult neurogenesis. Additionally, NA-Semax Amidate modulates melanocortin receptors (MC3R/MC4R), enhances dopaminergic and serotonergic neurotransmission, upregulates nerve growth factor (NGF) and glial cell-derived neurotrophic factor (GDNF), and activates the CREB transcription factor pathway. In ischemic stroke models, Semax-based compounds have demonstrated significant neuroprotection through anti-inflammatory cytokine modulation, reduction of oxidative stress, prevention of apoptotic cell death, and enhancement of neural repair gene expression programs.

NA-Semax Amidate is administered intranasally at 200–600 mcg per nostril, 1–3 times daily, with rapid onset of effects (15–30 minutes) via olfactory and trigeminal nerve absorption pathways. Users typically report enhanced focus, mental clarity, verbal fluency, and mood elevation. The compound is most commonly paired with NA-Selank Amidate for a balanced nootropic protocol — Semax provides stimulatory, dopaminergic, and BDNF-enhancing activity while Selank contributes anxiolytic GABAergic modulation, yielding cognitive enhancement without overstimulation. In broader stacks, it complements cholinergic agents like alpha-GPC, neuroplasticity enhancers like lion's mane, and racetam nootropics. Side effects are rare and mild, typically limited to nasal irritation or transient headache.

Mechanism of Action

Dual Stability Modifications

NA-Semax Amidate is the most proteolytically resistant form of the Semax heptapeptide (Met-Glu-His-Phe-Pro-Gly-Pro). It features:

1. N-terminal acetylation — blocks aminopeptidase attack at the Met1 position (also preventing methionine oxidation)
2. C-terminal amidation — replaces the free carboxyl with an amide group, preventing carboxypeptidase degradation

These modifications synergistically extend the peptide's half-life while preserving binding to melanocortin receptors and maintaining the full nootropic/neuroprotective activity profile.

Neurotrophin Upregulation — The Core Mechanism

The defining pharmacological action of NA-Semax Amidate is its potent upregulation of neurotrophins. It increases hippocampal and cortical mRNA and protein levels of:

• BDNF — activating TrkB → MAPK/ERK, PI3K/Akt/mTOR, PLCγ/CaMKII
• NGF — activating TrkA → Ras/ERK, PI3K for cholinergic neuron survival
• NT-3 — supporting broader neuronal population maintenance

The BDNF response magnitude (up to 2x baseline in hippocampus) exceeds most peptide nootropics, supporting robust enhancement of long-term potentiation (LTP), dendritic spine remodeling, and adult hippocampal neurogenesis.

Melanocortin Signaling

As an ACTH(4-10) analog, NA-Semax Amidate retains significant affinity for MC3R and MC4R in the CNS. These receptors couple through Gsα → adenylyl cyclase → cAMP → PKA → CREB signaling. MC4R activation in the hippocampus and prefrontal cortex enhances memory consolidation and attention. Critically, the peptide lacks affinity for MC2R (the adrenal ACTH receptor), so it does not stimulate cortisol production — separating cognitive benefits from stress hormone effects.

Monoaminergic Modulation

NA-Semax Amidate enhances dopamine turnover in the prefrontal cortex and striatum by increasing tyrosine hydroxylase (TH) expression and modulating DAT activity. It similarly modulates serotonin via effects on TPH2 and SERT. These monoaminergic effects support improved working memory, cognitive flexibility, attention, and emotional regulation.

Neuroprotection in Acute Brain Injury

Semax-based peptides are clinically approved in Russia for acute ischemic stroke. The neuroprotective mechanism involves:

• Suppression of microglial activation and NF-kB-driven neuroinflammation
• Reduction of glutamate excitotoxicity through NMDA receptor modulation
• Blood-brain barrier stabilization via claudin and occludin preservation
• Promotion of angiogenesis and neurovascular unit survival through VEGF signaling
• Modulation of >1,000 genes involved in inflammation, apoptosis, and repair

The dual stability modifications of NA-Semax Amidate may provide extended neuroprotective coverage in acute settings compared to unmodified Semax.

Reconstitution Calculator

Safety Profile

Side effects are generally mild, including potential hair loss, anxiety, and headaches, particularly if dosed incorrectly. It is contraindicated for individuals with acute illnesses or those who are pregnant or breastfeeding. Long-term effects are unknown, and it should not be combined with other psychoactive substances without medical supervision.

Pharmacokinetic Profile